By Ludwig Burger FRANKFURT (Reuters) -Germany’s Merck KGaA on Thursday warned of a steeper earnings decline on a slump in demand for materials used to produce pharmaceuticals and semiconductors, as its high-tech…
(Reuters) – Mersana Therapeutics Inc said on Thursday it had signed a deal for developing cancer drugs with Germany’s Merck KGaA that has the potential to generate up to $800 million in…
FRANKFURT (Reuters) – Germany’s Merck KGaA on Monday said it aims to double the productivity of its research and development into oncology, neurology and immunology treatments. As part of the productivity push,…
By Michael Erman (Reuters) – Drugmaker Merck & Co avoided billions of dollars of U.S. taxes in recent years on its top-selling cancer drug Keytruda by booking all the profits from the…
(Reuters) -Finnish drug maker Orion on Wednesday raised its full year outlook after it signed a collaboration agreement with Merck aimed at developing a prostate cancer drug, sending its shares to two-year…
(Reuters) – Drugmaker Merck & Co is considering buying cancer-focused biotech company Seagen Inc, the Wall Street Journal reported on Friday, citing people familiar with the matter. Talks have been underway for…
TOKYO – The Japanese unit of Merck & Co Inc said on Monday it would accelerate imports of its oral COVID-19 treatment to help with a surge in cases caused by the…
Merck announced Friday that updated data on its experimental COVID-19 pill show the drug is less effective than previously reported, and will now move to test treatment for safety. Merck said the…